about
Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trialHow to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study.Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.The TRUFFLE study; fetal monitoring indications for delivery in 310 IUGR infants with 2 year's outcome delivered before 32 weeks of gestation.Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.Longitudinal study of computerized cardiotocography in early fetal growth restriction.Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life.Prediction of recurrence of hypertensive disorders of pregnancy in the term period, a retrospective cohort study.Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a Delphi procedure.Building consensus and standards in fetal growth restriction studies.Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study.Fetal growth and risk assessment: is there an impasse?CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trialEssential variables for reporting research studies on fetal growth restriction - a Delphi consenusUsing cerebroplacental ratio in non-SGA fetuses to predict adverse perinatal outcome: caution is requiredThe prognostic accuracy of short term variation of fetal heart rate in early-onset fetal growth restriction: A systematic reviewChronic hypertension in pregnancy: an unique opportunityA core outcome set for hyperemesis gravidarum research: an international consensus studyVariation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restrictionComputerized fetal heart rate analysis in early preterm fetal growth restrictionTemporal variation in definition of fetal growth restriction in the literatureBlood pressure of 12-year-old children born after foetal growth restriction due to hypertensive disorders of pregnancy; relation to neonatal, life style, and family characteristicsNeurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial'Blindness out of the womb', a historical account of the first report of posterior reversible encephalopathy syndrome (PRES): choose your title well or your findings will be neglectedCore outcome set for studies investigating management of selective fetal growth restriction in twinsComparative analysis of 2-year outcomes in GRIT and TRUFFLE trialsA Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE studyNeonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trialFetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study
P50
Q37252634-CFAA643D-4AE2-48DB-85A7-A8D94F43986AQ38969850-F3182FED-B778-47B0-AF8F-495CA43C3998Q39169771-7AE4D395-E413-4F12-AFBD-736C5344FCD3Q39181225-721844B8-41D9-4320-83B7-C447BEF0CC86Q39238730-D385FC13-1851-49DB-9247-58524BA533EEQ39532886-7E631285-CC8A-4F85-AB07-253533ED147CQ40331475-3FA7DB96-C142-4D98-8096-E68E19ABA0F2Q40806082-6F0DD652-02E5-41F4-AE7D-810922BE2614Q47715162-B254B0E0-5542-4B23-9059-B7785F6544B6Q52632826-95F199F1-AE43-45E1-86E6-82C1AB4BFA2CQ55332174-FAA9A643-FA7B-45F8-B760-4F813EC8C960Q57477612-8E5046DB-DF78-4E4A-A559-3C0B5B780E68Q58623778-95ED6F77-D8CF-4FE4-AD39-303A8F6407A0Q59677568-33762D36-11C1-47AE-AFEB-037881D992E4Q61850327-26698F2F-0A2C-4C00-B6EC-2A9B62F1714EQ63358835-01A6A144-01C1-402B-BBC4-DF7EB1626D16Q89048970-B66B226E-FAF7-4504-87FC-B5ECAC6D18BAQ89707656-BD3C31DB-0EFF-453A-8308-0EEA97B72147Q90320110-5B8C5C14-F97F-4E20-8554-AAC403DD137CQ90666558-C4CAD5F8-A4F5-4B65-A798-2F79764FEF18Q90767303-59C31102-0B11-4216-9482-071930B8170DQ91121407-2993221C-57D7-443F-86A2-EE79E4DA2677Q91125492-2296349E-F59A-42E3-9B68-D9711DF4616CQ91408129-4C104475-6D2C-4C51-9D0E-B4DAC31D8844Q91626848-C09D195D-4997-48AC-927C-C27AF3C35B50Q92270685-4772CABE-BEAC-4F62-B34B-299144BEAA2CQ92455571-01A9262D-A2A7-41B9-9200-17C51F1FBE6DQ92799828-A455631F-B80F-4642-B868-A43FA76F4C1DQ96585382-33A7B8CF-BEF0-4B9A-B1CB-E68CC6E5C699
P50
description
researcher ORCID ID = 0000-0002-7243-2115
@en
name
Wessel Ganzevoort
@ast
Wessel Ganzevoort
@en
Wessel Ganzevoort
@es
Wessel Ganzevoort
@nl
type
label
Wessel Ganzevoort
@ast
Wessel Ganzevoort
@en
Wessel Ganzevoort
@es
Wessel Ganzevoort
@nl
prefLabel
Wessel Ganzevoort
@ast
Wessel Ganzevoort
@en
Wessel Ganzevoort
@es
Wessel Ganzevoort
@nl
P31
P496
0000-0002-7243-2115